← Back to Search

Case Management for Advanced Cancer

N/A
Waitlist Available
Led By Andrea Cheville, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Sufficient auditory acuity
Intact cognitive status
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 6 months
Awards & highlights

Study Summary

This trial studies how well collaborative targeted case management works in improving functional status in patients with stage III-IV cancer.

Who is the study for?
This trial is for English-speaking adults with stage III or IV cancer who can fill out questionnaires, have a working phone, good hearing, clear thinking skills, and are expected to live more than 6 months. They should be somewhat mobile but not recently had major surgery.Check my eligibility
What is being tested?
The study tests if special case management helps improve movement, quality of life, and pain in advanced cancer patients. It includes therapy management education, physical therapy sessions, regular check-ins by phone and tracking health outcomes.See study design
What are the potential side effects?
Since this trial focuses on supportive care rather than drugs or invasive treatments, side effects may include discomfort from physical activities or emotional distress from discussing health issues during educational or telephone interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can hear well enough for daily activities.
Select...
My thinking and memory skills are normal.
Select...
My cancer is in stage III or IV.
Select...
My ability to move and care for myself is moderately impaired.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional mobility, as measured by the change in the Activity Measure for Post Acute Care (AM PAC) Computer Adaptive Test (CAT) from baseline [6 months]
Secondary outcome measures
Discharge location from hospital
Health Utility, as measured by the change in EuroQol 5-D (5Q-5D) scale score from baseline
Hospital length of stay
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Arm III (enhanced usual, RCM, PCM)Experimental Treatment8 Interventions
Patients undergo enhanced usual care as in Arm I, participate in an individualized conditioning program coordinated by the FCM as in Arm II, and receive optimized pain management through a nurse Pain Care Manager (PCM) for 6 months.
Group II: Arm II (enhanced usual care, RCM)Experimental Treatment8 Interventions
Patients undergo enhanced usual care as in Arm I and participate in an individualized conditioning program delivered telephonically by the Fitness Care Manager (FCM) and adapted, as required, by a local physical therapist for 6 months.
Group III: Arm I (enhanced usual care)Experimental Treatment5 Interventions
Patients undergo enhanced usual care comprising telephonic monitoring with monthly status reports provided to their oncology care teams for 6 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
management of therapy complications
2008
Completed Phase 3
~3940
physical therapy
2019
Completed Phase 4
~1500
quality-of-life assessment
2012
Completed Phase 3
~2780
telephone-based intervention
2009
Completed Phase 1
~920
assessment of therapy complications
2008
Completed Phase 3
~7930

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,179 Previous Clinical Trials
3,757,935 Total Patients Enrolled
31 Trials studying Pain
5,292 Patients Enrolled for Pain
National Cancer Institute (NCI)NIH
13,615 Previous Clinical Trials
40,918,104 Total Patients Enrolled
97 Trials studying Pain
17,186 Patients Enrolled for Pain
Andrea Cheville, M.D.Principal InvestigatorMayo Clinic

Media Library

Collaborative Targeted Case Management Clinical Trial Eligibility Overview. Trial Name: NCT01721343 — N/A
Pain Research Study Groups: Arm II (enhanced usual care, RCM), Arm I (enhanced usual care), Arm III (enhanced usual, RCM, PCM)
Pain Clinical Trial 2023: Collaborative Targeted Case Management Highlights & Side Effects. Trial Name: NCT01721343 — N/A
Collaborative Targeted Case Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT01721343 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there availability in this research endeavor for potential participants?

"Reportedly, this clinical trial is not currently open to applicants. It was initially posted on November 7th 2012 and revised January 5th 2022; however 2719 other studies are actively recruiting at present."

Answered by AI
~42 spots leftby Mar 2025